PDF herunterladen
Thromb Haemost 2016; 115(02): 333-343
DOI: 10.1160/th15-04-0300
Cellular Haemostasis and Platelets
Schattauer GmbH

Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions

Giuseppe Guglielmini   *
1   Department of Medicine, Section of Internal and Cardiovascular Medicine, University Perugia, Italy
,
Viviana Appolloni   *
1   Department of Medicine, Section of Internal and Cardiovascular Medicine, University Perugia, Italy
,
Stefania Momi
1   Department of Medicine, Section of Internal and Cardiovascular Medicine, University Perugia, Italy
,
Philip G. de Groot
2   Department of Clinical Chemistry and Hematology, University Medical Centre, Utrecht, The Netherlands
,
Monica Battiston
3   Department of Translational Research, Stem Cell Unit, National Cancer Institute CRO-IRCCS, Aviano, Italy
,
Luigi de Marco
3   Department of Translational Research, Stem Cell Unit, National Cancer Institute CRO-IRCCS, Aviano, Italy
4   Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla ,California, USA
,
Emanuela Falcinelli
1   Department of Medicine, Section of Internal and Cardiovascular Medicine, University Perugia, Italy
,
Paolo Gresele
1   Department of Medicine, Section of Internal and Cardiovascular Medicine, University Perugia, Italy
› Institutsangaben Financial support: This study was supported in part by grants from Fondazione Cassa di Risparmio di Perugia (Protocol # 2014.0083.021), from MIUR (Protocol # 2012773NE3) to P. G., and from Fondazione Umbero Veronesi to E. F., and in part by an Erasmus Placement grant to V. A. and by a grant to L. D. M. from the Italian Ministry of Health RF-2010–2316198.
Weitere Informationen

Publikationsverlauf

Received: 10. April 2015

Accepted after major revision: 18. September 2015

Publikationsdatum:
22. November 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Summary

Platelets contain and release matrix metalloproteinase-2 (MMP-2) that in turn potentiates platelet aggregation. Platelet deposition on a damaged vascular wall is the first, crucial, step leading to thrombosis. Little is known about the effects of MMP-2 on platelet activation and adhesion under flow conditions. We studied the effect of MMP-2 on shear-dependent platelet activation using the O’Brien filtration system, and on platelet deposition using a parallel-plate perfusion chamber. Preincubation of human whole blood with active MMP-2 (50 ng/ml, i. e. 0.78 nM) shortened filter closure time (from 51.8 ± 3.6 sec to 40 ± 2.7 sec, p< 0.05) and increased retained platelets (from 72.3 ± 2.3 % to 81.1 ± 1.8 %, p< 0.05) in the O’Brien system, an effect prevented by a specific MMP-2 inhibitor. High shear stress induced the release of MMP-2 from platelets, while TIMP-2 levels were not significantly reduced, therefore, the MMP-2/TIMP-2 ratio increased significantly showing enhanced MMP-2 activity. Preincubation of whole blood with active MMP-2 (0.5 to 50 ng/ml, i.e 0.0078 to 0.78 nM) increased dose-dependently human platelet deposition on collagen under high shear-rate flow conditions (3000 sec-1) (maximum +47.0 ± 11.9 %, p< 0.05, with 50 ng/ml), while pre-incubation with a MMP-2 inhibitor reduced platelet deposition. In real-time microscopy studies, increased deposition of platelets on collagen induced by MMP-2 started 85 sec from the beginning of perfusion, and was abolished by a GPIIb/IIIa antagonist, while MMP-2 had no effect on platelet deposition on fibrinogen or VWF. Confocal microscopy showed that MMP-2 enhances thrombus volume (+20.0 ± 3.0 % vs control) rather than adhesion. In conclusion, we show that MMP-2 potentiates shear-induced platelet activation by enhancing thrombus formation.

Supplementary Material to this article is available online at www.thrombosis-online.com.

Keywords

Matrix metalloproteinases - platelet adhesion - shear stress - TIMP-2

* These authors contributed equally to this study.


 

  • References

  • 1 Gresele P, Falcinelli E, Momi S. Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. Trends Pharmacol Sci 2008; 29: 352-360.
    CrossrefPubMedGoogle Scholar
  • 2 Nieswandt B, Pleines I, Bender M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost 2011; (Suppl. 01) 92-104.
    PubMedGoogle Scholar
  • 3 Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res 2007; 100: 1673-1685.
    CrossrefPubMedGoogle Scholar
  • 4 Blair TA, Moore SF, Williams CM. et al. Phosphoinositide 3-kinases p110a and p110β have differential roles in insulin-like growth factor-1-mediated Akt phosphorylation and platelet priming. Arterioscler Thromb Vasc Biol 2014; 34: 1681-1688.
    CrossrefPubMedGoogle Scholar
  • 5 Lupia E, Bosco O, Mariano F. et al. Elevated thrombopoietin in plasma of burned patients without and with sepsis enhances platelet activation. J Thromb Haemost 2009; 07: 1000-1008.
    CrossrefPubMedGoogle Scholar
  • 6 Vezza R, Roberti R, Nenci GG. et al. Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C. Blood 1993; 82: 2704-2713.
    PubMedGoogle Scholar
  • 7 Wang JS, Cheng LJ. Effect of strenuous, acute exercise on alpha2-adrenergic agonist-potentiated platelet activation. Arterioscler Thromb Vasc Biol 1999; 19: 1559-1565.
    CrossrefPubMedGoogle Scholar
  • 8 Momi S, Falcinelli E, Giannini S. et al. Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. J Exp Med 2009; 206: 2365-2379.
    CrossrefPubMedGoogle Scholar
  • 9 Brass LF, Zhu L, Stalker TJ. Novel therapeutic targets at the platelet vascular interface. Arterioscler Thromb Vasc Biol 2008; 28: s43-50.
    CrossrefPubMedGoogle Scholar
  • 10 Seizer P, May AE. Platelets and matrix metalloproteinases. Thromb Haemost 2013; 110: 903-909.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 11 Busti C, Falcinelli E, Momi S. et al. Matrix metalloproteinases and peripheral arterial disease. Intern Emerg Med 2010; 05: 13-25.
    PubMedGoogle Scholar
  • 12 Santos-Martinez MJ, Medina C, Gilmer JF. et al. Matrix metalloproteinases in platelet function: coming of age. J Thromb Haemost 2008; 06: 514-516.
    CrossrefPubMedGoogle Scholar
  • 13 Sawicki G, Salas E, Murat J. et al. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997; 386: 616-619.
    CrossrefPubMedGoogle Scholar
  • 14 Trivedi V, Boire A, Tchernychev B. et al. Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell 2009; 137: 332-343.
    CrossrefPubMedGoogle Scholar
  • 15 Falcinelli E, Guglielmini G, Torti M. et al. Intraplatelet signalling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation. J Thromb Haemost 2005; 03: 2526-2535.
    CrossrefPubMedGoogle Scholar
  • 16 Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metallo-proteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839.
    CrossrefPubMedGoogle Scholar
  • 17 Kazes I, Elalamy I, Sraer JD. et al. Platelets release a trimolecular complex components MT-1- MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation. Blood 2000; 96: 3064-3069.
    PubMedGoogle Scholar
  • 18 Cecchetti L, Tolley ND, Michetti N. et al. Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. Blood 2011; 18: 1903-1911.
    PubMedGoogle Scholar
  • 19 Villeneuve J, Block A, Le Bousse-Kerdilés MC. et al. Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organisation for these secreted proteins. Exp Hematol 2009; 37: 849-856.
    CrossrefPubMedGoogle Scholar
  • 20 Falcinelli E, Giannini S, Boschetti E. et al. Platelets release active matrix metallo-proteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin. Br J Haematol 2007; 138: 221-230.
    CrossrefPubMedGoogle Scholar
  • 21 Gresele P, Falcinelli E, Loffredo F. et al. Platelets release matrix metalloprotei-nase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. Eur Heart J 2011; 32: 316-325.
    CrossrefPubMedGoogle Scholar
  • 22 Lenti M, Falcinelli E, Pompili M. et al. Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation. Correlation with ischaemic events. Thromb Haemost 2014; 111: 1089-1101.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 23 Choi WS, Jeon OH, Kim HH. et al. MMP-2 regulates human platelet activation by interacting with integrin alphaIIbbeta3. J Thromb Haemost 2008; 06: 517-523.
    CrossrefPubMedGoogle Scholar
  • 24 Soslau G, Mason C, Lynch S. et al. Intracellular matrix metalloproteinase-2 (MMP-2) regulates human platelet activation via hydrolysis of talin. Thromb Haemost 2014; 111: 140-153.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 25 Martinez A, Salas E, Radomski A. et al. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide. Sci Monit 2001; 07: 646-651.
    PubMedGoogle Scholar
  • 26 O’Brien JR, Salmon GP. Shear stress activation of platelet glycoprotein IIb-IIIa plus VWF causes aggregation: filter blockage and the long bleeding time in von Willebrand’s disease. Blood 1987; 70: 1354-1361.
    PubMedGoogle Scholar
  • 27 Gresele P, Guglielmini G, De Angelis M. et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 2003; 41: 1013-1020.
    CrossrefPubMedGoogle Scholar
  • 28 Gresele P, Marzotti S, Guglielmini G. et al. Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent. Diabetes Care 2010; 33: 1262-1268.
    CrossrefPubMedGoogle Scholar
  • 29 Sixma JJ, de Groot PG, van Zanten H. et al. A new perfusion chamber to detect platelet adhesion using a small volume of blood. Thromb Res 1998; 92: S43-46.
    CrossrefPubMedGoogle Scholar
  • 30 Momi S, Impagnatiello F, Guzzetta M. et al. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. Eur J Pharmacol 2007; 570: 115-124.
    CrossrefPubMedGoogle Scholar
  • 31 Rossiello MR, Momi S, Caracchini R. et al. A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression. J Thromb Haemost 2005; 03: 2554-2562.
    CrossrefPubMedGoogle Scholar
  • 32 Tersteeg C, de Maat S, De Meyer SF. et al. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy. Circulation 2014; 129: 1320-1331.
    CrossrefPubMedGoogle Scholar
  • 33 Van Os E, Wu Y-P, Pouwels JG. et al. Thrombopoietin increases platelet adhesion under flow and decreases rolling. Br J Haematol 2003; 121: 482-490.
    CrossrefPubMedGoogle Scholar
  • 34 Goto S, Tamura N, Ishida H. Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions. J Am Coll Cardiol 2004; 21 44: 316-323.
    CrossrefPubMedGoogle Scholar
  • 35 Cozzi MR, Guglielmini G, Battiston M. et al. Visualisation of nitric oxide production by individual platelets during adhesion in flowing blood. Blood 2015; 125: 697-705.
    CrossrefPubMedGoogle Scholar
  • 36 Mendolicchio GL, Zaloni D, Bacci M. et al. Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood. J Thromb Haemost 2011; 09: 373-382.
    CrossrefPubMedGoogle Scholar
  • 37 O’Brien JR, Etherington MD, Brant J. et al. Decreased platelet function in aortic valve stenosis: high shear platelet activation then inactivation. Br Heart J 1995; 74: 641-644.
    CrossrefPubMedGoogle Scholar
  • 38 Menegatti M, Cristalli G, Gallo L. et al. Effect of adenosine derivatives on in vitro thrombus formation induced by shear stress. Haematologica 1999; 84: 721-725.
    PubMedGoogle Scholar
  • 39 Chow TW, Hellums JD, Moake JL. et al. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood 1992; 80: 113-120.
    PubMedGoogle Scholar
  • 40 Brass LF, Shattil SJ. Changes in surface-bound and exchangeable calcium during platelet activation. J Biol Chem 1982; 257: 14000-14005.
    PubMedGoogle Scholar
  • 41 Moake JL, Turner NA, Stathopoulos NA. et al. Shear-induced platelet aggregation can be mediated by VWF released from platelets, as well as by exogenous large or unusually large VWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988; 71: 1366-1374.
    PubMedGoogle Scholar
  • 42 Schulze CJ, Wang W, Suarez-Pinzon WL. et al. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myo-cardial ischaemia-reperfusion injury. Circulation 2003; 107: 2487-2492.
    CrossrefPubMedGoogle Scholar
  • 43 Nguyen M, Arkell J, Jackson CJ. Human endothelial gelatinases and angiogen-esis. Int J Biochem Cell Biol 2001; 33: 960-970.
    CrossrefPubMedGoogle Scholar
  • 44 Kroll MH, Hellums JD, McIntire LV. et al. Platelets and shear stress. Blood 1996; 88: 1525-1541.
    PubMedGoogle Scholar
  • 45 Kulkarni S, Dopheide SM, Yap CL. et al. A revised model of platelet aggregation. J Clin Invest 2000; 105: 783-791.
    CrossrefPubMedGoogle Scholar
  • 46 Saelman EU, Hese KM, Nieuwenhuis HK. et al. Aggregate formation is more strongly inhibited at high shear rates by dRGDW, a synthetic RGD-containing peptide. Arterioscler Thromb 1993; 13: 1164-1170.
    CrossrefPubMedGoogle Scholar
  • 47 Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 2008; 28: 403-412.
    CrossrefPubMedGoogle Scholar
  • 48 Brass LF, Wannemacher KM, Ma P. et al. Regulating thrombus growth and stability to achieve an optimal response to injury. J Thromb Haemost 2011; 09: 66-75.
    CrossrefPubMedGoogle Scholar
  • 49 Maxwell MJ, Westein E, Nesbitt WS. et al. Identification of a 2-stage platelet aggregation process mediating shear-dependent thrombus formation. Blood 2007; 109: 566-576.
    CrossrefPubMedGoogle Scholar
  • 50 Gear AR, Suttitanamongkol S, Viisoreanu D. et al. Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood 2001; 97: 937-945.
    CrossrefPubMedGoogle Scholar
  • 51 Kraemer BF, Schmidt C, Urban B. et al. High shear flow induces migration of adherent human platelets. Platelets 2011; 22: 415-421.
    CrossrefPubMedGoogle Scholar